CURRICULUM VITAE

NUME: - TUDOR D. CORINA

DATA NASTERII: - Bucuresti 16. 04 .1966

STUDII: - Facultatea de Medicina , Universitatea de Medicina “Carol Davila" 1991

PROFESIA: - Medic Specialist Psihiatrie Prin Ordinul M.S Nr. 900/1999 in sesiunea din 20 10

- Medic primar psihiatrie in urma examenului sustinut in 12. 06. 2006

EXPERIENTA PROFESIONALA:

- 01. 11. 1991- 10 .02. 1993 medic stagiar la Spitalul Clinic Caritas

- 27. 02. 1995-29. 02. 2000 medic rezident la Spitalul Clinic de Psihiatrie “Prof dr

Alexandru Obregia”

- 15. 06. 2000-31. 12 .2001 medic specialist cdta “grigore cobalcescu”

- 01. 01. 2002 - prezent medic specialist la Clinica Psihiatrie la Spitalul Universitar de Urgenta Militar

Central Bucuresti

- Membru in Liga Romana de Sanatate Mentala.

CURSURI DE PERFECTIONARE

1. Introducere in psihoterapie si sfatuirea familiei copilului cu tulburari neuropsihice

*ciclul i: 30. 12. 1996

*ciclul ii: 15. 01. 1998

*ciclul iii: 15. 01. 1999

2. Dezvoltarea unui model de ingrijire comunitara pentru varstnici 22 - 23.04.1996

3. Psihofarmacologia tulburarilor depresive 03 - 07.04.2000

4.Schizofrenia –baze neurobiologice si psihomarmacologice 20 - 22. 12.2000

5. Scientific aspects of clinical trials in psychiatry Vienna School of Clinical Research 06 – 11.07.2003

6. Disfuntii sexuale- etiopatogenie si tratament 24.02.2005

7.ZypaAdhera Informational Meeting,Berlin 25-26.03.2010

LUCRARI PUBLICATE:

- “Declinul viziunii clasice asupra spitalului psihiatric “- Revista Romana de Sanatate Mintala nr.

10/1998 (2)

- “Tratamentul farmacologic al dependentei de heroina”- Revista Romana de Psihiatrie , Nr3-4,

Vol.III; 2001; pg 170 - 174 Participari La Conferinte: Conferinta Nationala de Psihiatrie, Bucuresti,

- 24 - 25. 10 .1997 “Antidepresive din a 3-a generatie in tratamentul starilor depresive”

PARTICIPARI CONGRESE NATIONALE SI INTERNATIONALE

1. Conferinta Nationala de Psihiatrie Bucuresti 24-25.10.2009

“Antidepresive din a treia generatie in tratamentul starilor depresive” Dr. Marie-Jeanne

Georgescu, Dr. Corina Tudor

2. Conferinta Nationala de Psihiatrie, Spitalul Clinic de Psihiarite “Prof. Dr. Alexandru Obregia

75 ani de existenta”08-10. 10. 1998

„Istoricul manifestarilor stiintifice psihiatrice antebelice din Romania” I. C. Cucu, A. Florea,

C. Tudor, D. Deceanu, M. Danila

3. Conferinta Nationala de Pishiatrie Brasov 25-26. 06. 1999 “Problematica actuala privind

relatia intre distimie si tulburare depresiva a personalitatii”

4. Al IV lea Congres National de Psihoterapie 27-30.05.1999

5. Congresul National de Psihiatrie “Psihiatrie 2000-Traditie si Perspective” 04-07.10.2000

6. Conferinta Nationala “Terapie si Management in Psihiatrie” Craiova, 25-27 10 2001:

„Strategii actuale si perspective in tratamentul depresiei refractare” M.D. Gheorghe, Anca

Dragan, Corina Tudor, R. Ciurea, S. Isacu

„Depresia recurenta- perspective profilactice si terapeutice” M.D. Gheorghe, Anca Dragan,

Corina Tudor, R. Ciurea

7. Alzheimer Europe XIth Conference 10-12.06.2001

8. 7th

ECNP Regional Meeting, Bucuresti, 19-21.04.2002

“Resistant Depression-psychopharmacological Strategies” M.D.Gheoghe, Corina Tudor, Anca

Dragan, R. Ciurea, S. Isacu

„The prolactin response of atypical anti psychotics” M.D. Gheorghe, Corina Tudor, R.

Ciurea, A. Giosa

„Efficacy of rivastigmine on cognitive end behavioral symptoms in patients with Alzheimer`s

disease” A. Baloescu, Corina Tudor, D. Vasile, R. Ciurea, M.D.Gheorghe

9. 16 Th

ENP Congress, Praga 20-24.09.2003

10. Al II lea Congres National de Psihiatrie 02-04.10.2003

„Assesment Of Sexual Disfunction In Depressive Patients Treated With Sertraline” Corina Tudor,

G. Grigorescu, R. Ciurea, M.D. Gheorghe

11. A VIII-a Editie a Congresului pentru studenti si tineri medici, Bucuresti 01-04. 2004

„Sindromul Serotoninergic” C. Nanea, Corina Tudor, M.D. Gheorghe

12. 17 TH

ECNP Congress Stockholm 09-13 10 2004

„Clinical Assement of Nassa vs SSRI -Efficacy In Major Depressive Episode” Corina Tudor, G.

Grigorescu, M.D. Gheorghe, D. Marinescu

13. A VIII-A Consfatuire Nationala De Psihiatrie Militara 22-24 10 2004

„Factori de Risc pentru Suicid” Dr. Corina Tudor

14. Forumul de Psihiatrie 2004

15. Forumul de Psihiatrie 2005

16. 11th Congres of Balkan Military Medical Committee Atena 18-22.06.2006

„Clinical efficacy and therapeutic compliance of atypical antipsychotics in first episod of

schizophrenia ” Ungureanu D., Tudor C., Vochescu C., Luchian A., Nanca A., Nanea C., G-ral

Prof. Gheorghe M.D.

17. Al 2-lea Congres National de Medicina Nucleara 8-11.11.2006, Bucuresti, „Prim episod

schizofrenic – Evaluare SPECT cerebrala de perfuzie pre si post-tratament cu antipsihotice

atipice” Rimbu A., Marinescu G, Mititelu R, Ghita S, Mazilu C, Vasile D, Baloescu A, Tudor C,

Isacu S, Vasiliu O, Gheorghe M.D, Codorean I. p.110-111

18. 12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

„Hypothyroidism presenting as psychosis: „mixedema madness” case report” C. Spiroiu,

A.E.Ranetti, A. Mazilu, D. Vasile, C.Tudor, O.Vasiliu.

19.Forumul de Psihiatrie 2007

20.Forumul de Psihiatrie 2008

21.21st ECNP Congress Barcelona 30.08-3.09.2008

„Aripiprazol swicth-on in chronic schizophrenia with atypical antipsychotics associated weight

gain” D.Vasile,O. Vasiliu, C. Tudor, D.Ungureanu, O. Cretu, M. Terpan

„Venlafaxine versus selective serotonin reuptake inhibitors in mixed major depression and

dysthymic disorder”, D.Vasiliu, O.Vasiliu, C.Tudor, D.Patriche, B.Stanescu, D.Ojog;

22.17th European Congress of Psychiatry Lisbon 24-28.01.2009

23.9th World Congress of Biological Psychiatry, Paris 2009;

„Efficacy of aripiprazole vs. quetiapine for the treatment of hostility in acute patients with

schizophrenia”, D. Vasiliu, G. Grigorescu, C. Tudor, O. Vasiliu, R. Grigorescu;

„Cognitive impairment profile in schizophrenia” G. Grigorescu, D. Vasile, C. Tudor, R.

Grigorescu

24.22nd ECPN Congress 12-16.09.2009 Istanbul, Turcia

„ Efficacy of trazodone in patients diagnosed with generalized anxiety disorder and

benzodiazepine dependence” M. Zavoianu, A. Luchian, C. Tudor, G. Grigorescu, D. Vasile

25. 2010 CINP International Congress, Hong Kong 6- 10 iunie 2010

,,Amisulprid augumentation versus standard antidepressant therapy in major depressive

disorder’’ G. Grigorescu, D. Vasile, O. Vasiliu, M-L. Vasile , Corina Tudor, A. Cantemir, M.

Zavoianu, A. G. Mangalagiu, M. Terpan, R. Grigorescu

26. 2010 CINP International Congress, Hong Kong 6- 10 iunie 2010

,,Low doses risperidone in cluster A personality disorder- a prospective study’’ D. Vasile, O.

Vasiliu, M. Terpan, M.-L. Vasile, Corina Tudor, V. Bogdan, A. G. Mangalagiu, G. Grigorescu, D.

Ojog

27. 2010 CINP Intyernational Congress, Hong Kong 6- 10 iunie 2010

,,Galantamine switch in donepezil non-responsive patients with early-onset Alzheimer dementia’’

D. Vasile, O. Vasiliu, Corina Tudor, M.-L. Vasile, G. Grigorescu, V. Bogdan, M. Terpan, A. G.

Mangalagiu, M. B. Petrescu, D. Ojog

28. 18-21 Oct 2014-the 27th ECNP congress, Berlin, Germany. Co author at SSRI

dose escalation versus duloxetine in treatment of major depressive disorder not responding to

initial SSRI

PARTICIPARI LA SEMINARII:

1. ”Psihoeducatia Pacientilor Schizofreni” Organizat de Liga Romana de Sanatate Mentala

21. 05. 1999

2.

3. “Actualitati in Terapia Depresiva” 12. 12 .2001

4. ”Alzheimer Europe XII th

Conference” 10-12 06 2001

4. ”Mit si Realitate Despre Mecanismul Dependentei la Benzodiazepine”07.10.2003

5. ”Forumul de Psihiatrie” 2004

6. Simpozion National de Neurologie “Progrese in Neuroprotectia si Neuroplasticitate a Sistemului

Nervos Central” 05-07.03.2004

7. Noi Orizonturi Terapeutice in Dementa 25.05.2004

8. “Insomnia problema serioasa de sanatate publica; aspecte clinice si practice” 04.05.2005

9. “Actualitati in tratamentul schizofreniei si al tulburarii afective bipolare” 02.04.2007

10. “Schizofrenie- istoric, particularitati etiopatogenice, de diagnostic, clinice si

terapeutice”14-15.04.2008

11. “Actualitati clinice si farmacologice in tulburarea depresiva majora”04,11.11.2008

12. “Noi abordari terapeutice in tratamentul psihiatric”11.04.2008

13. “Conduita terapeutica in epilepsie”02.07.2008

14. “Aspecte clinice fundamentale ale tulburarii afective bipolare” 2008

15. “Optiuni terapeutice actuale in tratamentul schizofreniei si al depresiei” 16.07.2009

16. “Depresia si patologia cardiovasculara raspunsuri la granita dintre specialitati” 24.11.2009

17. “Noi perspective terapeutice in patologia psihiatrica” 10.10.2009

18. Forumul de Psihiatrie 2005

19. A V-A Conferinta Nationala de Aterotromboza 01-02 04 2005

20. A VIII-A Conferinta Nationala de Aterotromboza 21-22.03.2008

PARTICIPARI LA STUDII CLINICE :

1.Studiu clinic noninterventional la pacientii cu depresie sub tratament cu Zoloft A 0501054-.

2000

2.RIS-ROM-01 2002

3.RIS-INT-87 01.02 2003-30.O6.2004

4.Constatre: Risperdal consta trial of relapse prevention and effectiveness (RISSCH3001), 2004

5. . EUFEST – The European First Episode Schizophrenia Trial, 2004

6. An eight-week, double-blind placebo-controlled, multicenter study evaluating the efficacy, safety

and tolerability of a fixed dose of SR 58611A (350 MG q12) in eldery patients with major

depressive disorder (MDD). Protocol: EFC 4846/07.nov.2005

7.PASTEL RISSCH4101-2007

8. An open-label, multi-center, 6-week, sequential cohort study designated to determine the safety

and tolerability of two dose ranges of BL-1020 in hospitalized subjects with chronic schizophrenia

or schizo-affective disorder, Phase IIa, 2007-2008

9.Studiu observational,retrospectiv la pacientii cu schizofrenie in faza acuta sau cronica

Amadeus-AMISU-L-02678 2008

10.A six-week, randomized, double-blind, placebo controlled, parallel, multicenter, IIb phase study

to determine the efficacy, safety, and tolerance of non-overlapping low and high doses of BL-1020

versus placebo and risperidone in patients with acute exacerbations of schizophrenia, 2008-2009

11. Studiu epidemiologic SEPTEMBER 23.09-13.11.2009

12. A multinational , double blind placebo controlled, dose ranging study to assess the efficacy and

safety of LU AA21004 in Patients with Major Depressive Disorder- Dec 2011-Apr 2012

13.Efficacy and Safety of agomelatine oral administration (25-50mg/day) in elderly subjects

suffering from Major depressive disorder, a 8 week randomized, double blind, flexible dose,

parallel groups, placebo-controlled, international, multicentre study followed by an extension

double blind treatment period of 16 weeks-phase 3- Jan 2010-Aug 2011

14. A phase 2, 6 Week, Multicenter, Randomized, Double Blind, Placebo Controlled Study to

evaluate the Efficacy, Safety and Tolerability of Oral OPC-34712 Once daily and aripiprazole once

daily for treatment of hospitalized adult patients with acute schizophrenia.

15. A phase 2, Multicenter, Open Label Study to Assess the Safety and Tolerability of Oral

OPC-34712 in Adult Patient with Schizophrenia-phase 2

16.A 12-week ,randomized, double-blind, multicentre study with parallel groups: agomelatine

(25mg/day given orally with blinded potential adjustment to 50mg/day) versus escitalopram

(10mg/day given orally with blinded potential adjustment to 20mg/day)-phase 3 study- June

2011-May 2013

17. Studiu observational privind Functionalitatea zilnica la pacientii cu depresie aflati sub Tratament

–Feb 2012-Iunie 2012

18. A phase 3, multi center , randomized, 24 week, double blind, parallel group, placebo controlled

study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant

negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, double

blind treatment period Sep 2011-ongoing

19. A phase 3, multi center , randomized, 24 week, double blind, parallel group, placebo controlled

study to evaluate efficacy and safety of RO4917838 in stable patients with sub-optimally

controlled symptoms of schizophrenia treated with antipsychotics followed by a 40 week double

blind, parallel group, placebo controlled treatment period- Mar 2012- ongoing

20. Efficacy and safety of 3 doses of S38093 (2,5 and 20mg/day) versus placebo in patients with mild

to moderate Alzheimer’s disease- A 24 week international, multi centre, randomized, double blind,

placebo- controlled phase IIb study followed by a 24-week extensive period.- Dec 2013-ongoing

21. A randomized, double blind , placebo controlled, phase 3 study to evaluate the efficacy and

safety of a once day, TAK-375 (Ramelteon) tablet for sublingual administration (TAK-375SL)

0.1mg and 0.4 mg as an adjunctive therapy in the treatment of acute depressive episodes associated

with Bipolar 1 Disorder in Adult subjects.

22.Efficacy and safety of tianeptine oral administration (25-50mg/day) in elderly patients suffering

from Major Depressive Disorder with escitalopram as active control.(2013-2014)

Dr. Tudor Corina